milnacipran has been researched along with Fatigue in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Doucette, JA; Eguale, T; Farag, HM; Goswami, H; Sultan, I; Yunusa, I | 1 |
| Flynn, D | 1 |
| Albrecht, KL; Bernstein, CD; Marcus, DA | 1 |
| Mease, PJ; Palmer, RH; Wang, Y | 1 |
| Chen, C; Fava, M; Freeman, MP; Gommoll, C; Greenberg, WM; Ruth, A | 1 |
| Antokhin, EY; Drobizhev, MY; Fedotova, AV; Kikta, SV | 1 |
| Blier, P; Chen, C; Gommoll, C; Kramer, K | 1 |
| Clauw, DJ; Gendreau, RM; Mease, P; Palmer, RH; Wang, Y | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
4 review(s) available for milnacipran and Fatigue
| Article | Year |
|---|---|
Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.
Topics: Amitriptyline; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Network Meta-Analysis; Pain; Pregabalin; United States; United States Food and Drug Administration | 2022 |
Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Cyclopropanes; Depression; Fatigue; Fibromyalgia; Humans; Milnacipran; Pain Management; Selective Serotonin Reuptake Inhibitors; Weight Loss | 2013 |
[Between depression and fibroniyalgia: the fate of the antidepressant].
Topics: Antidepressive Agents; Cyclopropanes; Depressive Disorder; Fatigue; Fibromyalgia; Humans; Milnacipran; Pain; Russia; Serotonin and Noradrenaline Reuptake Inhibitors | 2016 |
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
2 trial(s) available for milnacipran and Fatigue
| Article | Year |
|---|---|
Effects of milnacipran on the multidimensional aspects of fatigue and the relationship of fatigue to pain and function: pooled analysis of 3 fibromyalgia trials.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Cyclopropanes; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
Topics: Adult; Aged; Capsules; Constipation; Cyclopropanes; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Pain; Pain Measurement; Patient Satisfaction; Placebos; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Vomiting | 2008 |
3 other study(ies) available for milnacipran and Fatigue
| Article | Year |
|---|---|
Chronic Pain Syndromes: Fibromyalgia.
Topics: Chronic Pain; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Milnacipran; Pregabalin | 2023 |
Effects of levomilnacipran ER on fatigue symptoms associated with major depressive disorder.
Topics: Activities of Daily Living; Adult; Antidepressive Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase III as Topic; Cyclopropanes; Delayed-Action Preparations; Depressive Disorder, Major; Fatigue; Female; Humans; Male; Middle Aged; Milnacipran; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Time Factors; Treatment Outcome | 2016 |
Effects of levomilnacipran ER on noradrenergic symptoms, anxiety symptoms, and functional impairment in adults with major depressive disorder: Post hoc analysis of 5 clinical trials.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Anxiety; Cluster Analysis; Cyclopropanes; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Fatigue; Female; Humans; Male; Middle Aged; Milnacipran; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2017 |